Discover 1,255 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,255
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: 54 recruiting locations
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: 18 recruiting locations
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase1, Phase2, Recruiting
Active & Responsive
Esprit BTK Post-Approval Study
for
Chronic Limb-Threatening Ischemia
Location: 28 recruiting locations
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06656364
Recruiting
Active & Responsive
Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris
for
Pityriasis Rubra Pilaris
Location: 1 recruiting location
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06444399
Phase2, Recruiting
Active & Responsive
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
for
Multifocal Motor Neuropathy
Location: 10 recruiting locations
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06537999
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
for
Lymphoma, B-Cell
Location: 7 recruiting locations
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT04884035
Phase1, Recruiting
Active & Responsive
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: 120 recruiting locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Active & Responsive
ASF Alport Patient Registry
for
Alport Syndrome, Thin Basement Membrane Disease,
Location: 1 recruiting location
Sponsor: Alport Syndrome Foundation
Sex: All
Age: 0+
Code: NCT06526741
Recruiting
Active & Responsive
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis